Regulatory & Legal

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

Operational failures at a key new mine pushed Peabody to a Q1 loss, overshadowing strong thermal coal profits fueled by geopolitical conflict.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

PowerBank's new 4.99 MW battery in Cramahe is online, boasting a lucrative 22-year contract and a groundbreaking 50% First Nations ownership stake.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

New data reveals 61% of LGBTQ+ youth report poor mental health, yet a near-unanimous 97% find powerful reasons for hope amidst the struggle.

A new geological report confirms gold potential at Treasure Canyon, but for a company with no revenue, the path to riches is paved with high risk.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

As Saudi Arabia targets a 1.5GW data capacity by 2030, Datalec Precision Installations enters the market to build the infrastructure for this digital boom.

Figure Technology Solutions reports a 108% YoY surge in loan volume, signaling strong adoption of its blockchain-native financial products and tokenized assets.

A new report reveals a major gap between executive AI ambitions and daily agent reality, as teams face rising strain despite technological advances.

Marking its 10th anniversary, The War Zone rebrands to TWZ, expanding its digital footprint to meet growing demand for in-depth defense journalism.